Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
ELISA OYJ | ELISA | Nasdaq Helsinki +6 Other | 294,658 | 42.7 EUR | Stock | |
ELISA OYJ | EIA | Deutsche Boerse AG | 24 | 42 EUR | ||
ELISA OYJ | 0I8Y | London S.E. | - | 42.65 EUR | ||
ELISA OYJ | EIA | Börse Stuttgart | - | 42.24 EUR | ||
ELISA OYJ | EIA | BOERSE MUENCHEN | - | 42.8 EUR | ||
ELISA OYJ | ELMUF | OTC Markets | 629 | 45.16 USD | ||
ELISA OYJ | EIA | Berne S.E. | - | - CHF | ||
ELISA OYJ | ELMUY | OTC Markets | 27 | 24 USD | Stock | |
ELISA OYJ (EI6) - ELA/C5 | Euronext Amsterdam | - | 42.18 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C6 | Euronext Amsterdam | - | 42.53 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C2 | Euronext Amsterdam | - | 42.56 EUR | Future | ||
ELISA OYJ (EI6) - ELA/20241220 | Euronext Amsterdam | - | 42.47 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C1 | Euronext Amsterdam | - | 42.4 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C3 | Euronext Amsterdam | - | 42.64 EUR | Future | ||
ELISA OYJ (EI6) - ELA/C4 | Euronext Amsterdam | - | 42.92 EUR | Future | ||
ELISA OYJ (EI6) - ELA/20240620 | Euronext Amsterdam | - | 42.8 EUR | Future |
News (6)
Companies (18)
Beijing Wantai Biopharmaceutical Co., Ltd. is a company mainly engaged in the research and development, production and sales of in-vitro diagnostics. The Company produces and sells in-vitro diagnostics, in-vitro diagnostic equipment and vaccines. The Comp ...
Elisa Oyj is the No. 1 private telecommunications company in Finland. Net sales break down by activity as follows: - mobile telephone service (59.2%); - fixed telecommunication (40.8%): fixed telephone service and broadband Internet access, TV broadcast ...
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is a Turkey-based company engaged in the research, development and production of in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media ...
Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Companyâs portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test ...
Soprocal Calerias e Industrias SA is a Chile-based company engaged in the acquisition and exploitation of mineral deposits as well as the production of calcium carbonate, quicklime, lime off, hydraulic lime, as well as other related derivatives. As of Dec ...
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa det ...
AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood c ...
Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, ...
American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of ...
1000mercis specializes in providing interactive advertising and marketing services. Net sales break down by activity as follows: - interactive marketing services (45.2%): develops market segment studies and satisfaction questionnaires, processes collecte ...
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing r ...
Bioventix plc is a United Kingdom-based company specializing in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, such as in automated immunoassays used in blood testing. The antibodies ...
Aptamer Group plc is a United Kingdom-based company that develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications. The Company's Optimer platform delivers next-generation ...
Bioqual, Inc. is engaged in performing contract research services, which is focused on in vivo models of human diseases, including COVID-19, acquired immune deficiency syndrome (AIDS), influenza, Mpox, respiratory syncytial virus (RSV) infection, Flavivir ...
Spring Art Holdings Berhad is a Malaysia-based investment holding company. The Company, through its subsidiary, Spring Art Industries Sdn. Bhd., is principally involved in the manufacturing of ready-to-assemble furniture products, where it undertakes the ...
ViroGates A/S is a Denmark-based medical technology company. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflect ...
Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its ca ...
Techlab Inc. (Techlab) is a medical device diagnostic product manufacturer. The Company develops and manufactures intestinal diagnostics worldwide. Techlab manufactures a variety of in vitro enteric diagnostics to determine Clostridium difficile, Escheric ...
Insiders
Currently, Elisa Patrizi occupies the position of Head-Operations & Maintenance at Infrastrutture Wireless Italiane SpA. In the past Ms. Patrizi was Manager-Wireless Development at Telecom Italia SpA. She received an undergraduate degree from Università degli Studi di Roma Tor Vergata.
Francesco Patrizi currently works as a Chief Executive Officer & Director at Società Emiliana Trasporti Autofiloviari S.p.A.
Tony Marco Patrizi is the founder of GR Engineering Services Ltd., a company he founded in 2006.
He currently holds the title of Managing Director & Executive Director at the firm.
In addition to his founding position, Mr. Patrizi has also held former positions.
From 2016 to 2018, he served as an Independent Non-Executive Director at Primary Gold Ltd.
He also worked as an Operations Manager at JR Engineering Services Pty Ltd.
Scott Patrizi is a professional with experience in various non-executive director roles.
He is currently a Non-Executive Director at Forrestania Resources Ltd.
Prior to this, he was the President, Chief Executive Officer & Director at Huntsman Exploration, Inc. from 2021 to 2023.
He also served as a Non-Executive Director at Elixir Energy Ltd.
from 2016 to 2019, and at Rarex Ltd.
from 2016 to 2020.
Additionally, he briefly served as a Non-Executive Director at Caprice Resources Ltd.
in 2021.
Patrizi holds an undergraduate degree from The University of Western Australia Business School.
Stefano di Patrizi has a current job as a Director at Askanews SpA.
Elisa Lee worked as an Attorney at Latham & Watkins LLP from 2000 to 2008.
She then worked as Senior Counsel at The Cooper Cos., Inc. in 2008 and as Assistant General Counsel at CooperVision, Inc. in 2009.
From 2009 to 2014, she worked at ICE Mortgage Technology, Inc. as Secretary, Executive VP & General Counsel.
She also worked as Secretary & Chief Legal Officer at Plex Systems, Inc. Ms. Lee holds an undergraduate degree from the University of California, Berkeley and a graduate degree from New York University.
Elisa B.
Gesalta worked as a Vice President at PLDT, Inc. from 2006 to 2020.
She obtained an undergraduate degree from the University of Santo Tomas.
Elisa Corghi is currently an Independent Director at Recordati SpA.
She also holds director positions at Nexi Payments SpA, Nexi SpA, Pitti Immagine Srl, Corneliani SpA, and RE Valuta SpA.
Previously, she served as an Independent Director at BasicNet SpA and Tinexta SpA.
Ms. Corghi's former roles include Senior Brand Manager-Sottilette Kraft at Mondelez International, Inc., Analyst at Intermonte Sim SpA, and Brand Manager at Barilla Alimentare SpA.
She obtained her undergraduate degree from the University of Bocconi in 1996.
Elisa Nardi worked as a Managing Director-People at Virgin Media, Inc. and as a Chief People Officer at The British United Provident Association Ltd.
Elisa Hebb is currently the EVP-Clinical Development & Regulatory Affairs at Endologix LLC since 2018.
Prior to this, she held the position of Vice President-Clinical & Regulatory Affairs at Crux Biomedical, Inc. starting in 2008 and Vice President-Clinical Affairs at Apneon, Inc. starting in 2007.
Ms. Hebb's former positions include Director-Clinical Programs at Boston Scientific Corp., Senior Director-Global Clinical Affairs at Philips Image Guided Therapy Corp.
from 2014 to 2015, and Senior Director-Clinical Affairs at Wallace Enterprises, Inc. Ms. Hebb completed her undergraduate degree at the University of California, Berkeley.
Elisa Bruce has worked as a Vice President at Fifth Third Bank, NA in Cincinnati, Ohio.
Elisa Lumbantoruan currently works at PT ISS Indonesia, as President Director & Chief Executive Officer from 2015 and PT Indosat Tbk, as Independent Commissioner from 2022.
Mr. Lumbantoruan also formerly worked at PT Garuda Indonesia (Persero) Tbk, as Executive VP, Director-Marketing & Sales from 2012 to 2013, PT Compaq Computer Indonesia, as Director-Marketing, PT Digital Astra Nusantara, as Director-Marketing, PT Hewlett-Packard Financial Services, as Director, PT Hewlett-Packard Indonesia, as President Director from 2002 to 2007, PT Samora Usaha Makmur, as EVP, Director-Human Capital, IT & Strategy, PT Astra Graphia Tbk, as Manager-Accounts, PT XL Axiata Tbk, as Independent Commissioner from 2008 to 2012, PT Garuda Indonesia (Persero) Tbk, as Independent Commissioner, Oracle Systems Asia Tenggara Pte Ltd., as Manager-Country Alliance, PT Cipta Arta Graha Informasi, as Manager-Sales, PT Gapura Angkasa, as President Commissioner from 2012 to 2013, and PT Citilink Indonesia, as President Commissioner from 2008 to 2013.
Mr. Lumbantoruan received his undergraduate degree in 1985 from Institut Teknologi Bandung.
Elisa Albendea currently works as a Marketing Manager at DSG Ireland Ltd.
Elisa Schupp has worked as a Director at the Canadian Investor Relations Institute since 2012 and as Vice President-Channels & Strategic Sales at CNW Group Ltd.
since 1984.
Elisa Freeman worked as a Senior Vice President-Distribution Operations at Discovery, Inc.
Elisa Belgacem worked as a Quantitative Researcher at Crédit Agricole Corporate & Investment Bank SA from 2013 to 2019.
She also worked as a Strategist at Crédit Agricole Cheuvreux SA.
Elisa Crotti is currently a Partner at RNT Invest Srl, Ticinese Building Srl, and Moffu Labs 2 Srl.
Previously, she worked as an Independent Director at SECO SpA, a Principal at The Boston Consulting Group, Inc., and an EVP-Strategy & Business Development at The Nuance Group AG.
Ms. Crotti holds an MBA from INSEAD and an undergraduate degree from Politecnico di Milano (conferral date: 1998).
Elisa Kruger worked as a Sales Manager at Panera Bread Co. from 2012 to 2013.
Elisa LeNoir
CHIEF COMPLIANCE OFFICER
Elisa is the Chief Compliance Officer at Lead Edge Capital.
Prior to joining Lead Edge, she was the Compliance Associate at JANA Partners LLC, an investment manager focusing on event-driven investing.
Elisa received her B.S.
in Psychology from the University of Florida, and her M.A.
in International Psychology from The Chicago School of Professional Psychology.
Elisa Manassa has a current job as the Head-Accounting at Yolo Group SpA.
Elisa Valeriani has a current job as an Independent Director at BPER Banca SpA.
Elisa Brown-Pruett currently works at Texas Campaign To Prevent Teen Pregnancy , Inc., as Director.
Elisa Facciotti is currently a Director at Fulltechnology Srl and Orchestra SRL.
She was previously an Executive Director at Softec SpA, a Member-Supervisory Board at Beewize SpA, and an Internal Auditor at Everel Group SpA.
Elisa Velazquez currently works as a Trustee for the New Jersey Dental Association.
Currently, she holds a job as a Trustee for the same organization.
Elisa Heslop currently works at Greenwich House, Inc., as Director from 2017.
Elisa Landers currently works as a Director at Boys & Girls Clubs of Portland.
Elisa Imelda has a current job as the Head of Finance, Accounting & Tax at PT Uni-Charm Indonesia Tbk.
Elisa Denise Turcot has worked as a Secretary at Green Mining Innovation, Inc. since 2023.
Elisa Baroncini is currently an Independent Non-Executive Director at Eni SpA.
She is also a Professor of International Law at Alma Mater Studiorum - Università di Bologna and a Member at World Investment Srl.
Previously, she served as the Co-Chairman of International Economic Law at the European Society of International Law from 2012 to 2022.
Elisa Janine Nasho currently works at Aviva Central Services UK Ltd., as Director from 2023.
Ms. Elisa A.
Mazen is a Managing Director, Head of Global Growth & Portfolio Manager at ClearBridge Investments LLC and at ClearBridge LLC.
In ClearBridge LLC, she is the head of firm's Global Growth Equity investment team and co-manages numerous global and international growth strategies.
In ClearBridge she is responsible for covering the consumer sector for firm's international and global growth portfolios.
She has over 39 years of investment industry experience.
Ms. Mazen joined ClearBridge from predecessor firm Global Currents Investment Management, which was founded in 2008 by a group of portfolio managers from Brandywine Global Investment Management.
Prior to joining Global Currents, she was a Managing Director and Head of the International and Global Equity Investments Group at Oppenheimer Capital, a division of Allianz Global Investors.
In addition, she was Executive Vice President and Portfolio Manager for the Central European Value Fund and had responsibility for a number of other funds at the firm.
Prior to Oppenheimer, she was a portfolio manager at Clemente Capital where she managed assets for public pension funds.
She began her career at Mitchell Hutchins Asset Management, now a subsidiary of UBS, in the High Yield investment area.
Ms. Mazen received her BA in Economics and Finance from Douglass College, Rutgers University.
Elisa O.
Abalajon is currently the Chief Human Resources Officer at Universal Robina Corp.
Her former job was as HR Director-Southeast Asia at Mondelez International AMEA Pte Ltd.
She received her undergraduate degree from Singapore Management University in 2013 and also attended Ateneo De Manila Law School for undergraduate studies.
Elisa Vall is currently a Director at Egis Group.
She previously worked as a Director at Egis SA.
Elisa Hyytiäinen currently works as a Director at Ammattiliitto Pro ry.
Elisa Luciano has held positions as an Independent Director at Societa' Reale Mutua di Assicurazioni and as a Director at Italiana Assicurazioni SpA.
Elisa Stude Pye currently works as a Director at the Houston Arboretum & Nature Center.
Elisa Ambrogio currently works at Ambrogio NV, as Director.
No results for this search
- Stock Market
- Advanced search
- Elisa Patrizi